Results The proportions of patients who discontinued study drug in Studies 2, 3, and 4 was 16.0% for the WEGOVY-treated group and 19.1% for the placebo-treated group, and 6.8% of patients treated with WEGOVY and 3.2% of patients treated with placebo discontinued treatment due to an adverse reaction [see Adverse Reactions (6.1)]
If you're struggling, talk to your medical team
Castelli adds, Our medical weight-loss program is evolving, and I am excited to offer the most effective and personalized medical treatments
Initially, fill out our intake form detailing your medical history and weight loss aims
Mycotoxins affecting Animals, Foods, Humans, and plants: Types, Occurrence, Toxicities, action Mechanisms, Prevention, and detoxification Strategies-A revisit
So keep the bottles clean